A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
PHASE2
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium
N/A
This observational study will document to what extent in daily clinical pra...
Status
Completed
Location
Multiple Locations
Start Date
2013-06-05
Trial ID
NCT01845818
Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
N/A
This observational study aims to identify genes that may affect how patient...
Status
Recruiting
Location
Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center
The study objective is aimed to describe all country, site, investigator an...
Status
Unknown
Location
Multiple Locations
Start Date
2022-04-30
Trial ID
NCT05190484
SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases
N/A
A prospective, longitudinal, multicentre, observational cohort follow-up st...
Status
Unknown
Location
Nouvelle Clinique BONNEFON
Start Date
2022-11-24
Trial ID
NCT05598684
Subconjunctival Humira for Boston Keratoprosthesis
PHASE1
This trial is studying the safety and tolerability of receiving an injectio...